Correction: Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC).

This document is a correction notice for an article titled "Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC)" published in the Journal of Experimental & Clinical Cancer Research. The correction pertains to the funding section of the original article. The authors clarify that the research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government, the Commercialization Promotion Agency for R&D Outcomes (COMPA), and the Korea Medical Device Development Fund. The correction does not impact the overall findings or conclusions of the article. [Extracted from the article]